Type 2 Diabetes News and Research RSS Feed - Type 2 Diabetes News and Research

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Oral wellness can help save money

Oral wellness can help save money

The American Journal of Preventive Medicine recently published a study from United Concordia Dental that shows reduced hospitalizations and health care costs are possible when individuals with certain chronic conditions, or who are pregnant receive and maintain treatment for gum disease. [More]
New hope for people suffering from obesity and diabetes

New hope for people suffering from obesity and diabetes

White, brown and beige adipocytes, or fat cells, are inherently different. Each of these cell types has different functions and each plays its own role in metabolism. In the human body, white adipose tissue is by far the most prevalent. [More]
EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone). [More]
GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S. [More]
Taiwan researchers develop new optical device to detect early complication of diabetes sooner

Taiwan researchers develop new optical device to detect early complication of diabetes sooner

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes. [More]
Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

There is no cure for Alzheimer's disease and other forms of dementia, but the research community is one step closer to finding treatment. [More]
Research report on global insulin market

Research report on global insulin market

According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.99 billion in 2012 and is expected to grow at a CAGR of 6.1% from 2013 to 2019 to reach USD 32.24 billion in 2019. [More]
New book describes worldwide initiatives to prevent the crisis of obesity and diabetes

New book describes worldwide initiatives to prevent the crisis of obesity and diabetes

Prediabetes and Diabetes increasingly consume the healthcare community and remain priority areas that require immediate attention. [More]
Discovery could lead to new therapies for treating Type 2 diabetes, obesity

Discovery could lead to new therapies for treating Type 2 diabetes, obesity

Researchers at UT Southwestern Medical Center have identified neural pathways that increase understanding of how the brain regulates body weight, energy expenditure, and blood glucose levels - a discovery that can lead to new therapies for treating Type 2 diabetes and obesity. [More]
Autophagy prevents accumulation of toxic proteins associated with type 2 diabetes

Autophagy prevents accumulation of toxic proteins associated with type 2 diabetes

People with Type 2 diabetes have an excess of a protein called islet amyloid polypeptide, or IAPP, and the accumulation of this protein is linked to the loss of insulin-producing pancreatic beta cells. [More]
Blacks with depression and diabetes receive inadequate mental health treatment

Blacks with depression and diabetes receive inadequate mental health treatment

A new study in General Hospital Psychiatry confirms that Blacks with depression plus another chronic medical condition, such as Type 2 diabetes or high blood pressure, do not receive adequate mental health treatment. [More]
Researchers recommend low carbohydrate diet for Type 1 and Type 2 diabetes

Researchers recommend low carbohydrate diet for Type 1 and Type 2 diabetes

A new study involving researchers from the University of Alabama at Birmingham and other institutions says patients with Type 1 and Type 2 diabetes should eat a diet low in carbohydrates. [More]
Oregano and rosemary help lower glucose in blood

Oregano and rosemary help lower glucose in blood

The popular culinary herbs oregano and rosemary are packed with healthful compounds, and now lab tests show they could work in much the same way as prescription anti-diabetic medication, scientists report. [More]
Dynamic nuclear polarization: an interview with Professor Robert Griffin, Massachusetts Institute of Technology

Dynamic nuclear polarization: an interview with Professor Robert Griffin, Massachusetts Institute of Technology

DNP, or dynamic nuclear polarization, is an NMR technique which transfers polarization from the electron spins onto the nuclear spins, using constant microwave irradiation to enable the transfer. [More]
BP variability may be ‘CV risk integrator’

BP variability may be ‘CV risk integrator’

Increased variability in blood pressure may be an indicator of overall cardiovascular risk rather than being a risk factor per se, suggest researchers. [More]

Enhancing autophagy in pre-diabetic patients has potential to prevent onset of diabetes

Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide. [More]
New book addresses safe and effective exercises for overweight children

New book addresses safe and effective exercises for overweight children

Safe and Effective Exercise for Overweight Youth by Melinda Sothern, PhD, Director of Behavioral & Community Health Sciences and Professor of Research at the LSU Health Sciences Center New Orleans School of Public Health, provides exercise recommendations and guidelines specifically designed for overweight youth. [More]
Cholesterol-lowering statins may prolong lives of people with diabetic cardiovascular disease

Cholesterol-lowering statins may prolong lives of people with diabetic cardiovascular disease

Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association. [More]
Single injection of protein FGF1 enough to restore blood sugar levels

Single injection of protein FGF1 enough to restore blood sugar levels

In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. [More]
JRC publishes first comprehensive report on school food policies in Europe

JRC publishes first comprehensive report on school food policies in Europe

As part of the European Commission's efforts to help reduce childhood obesity, the Commission's in-house science service, the Joint Research Centre (JRC), has published the first comprehensive report on school food policies in Europe. [More]